Evidence map›Paper›PMID 30963094›Full record

ArticleInternational journal of cardiology. Heart & vasculature2019

Impact of the clinical frailty scale on mid-term mortality in patients with ST-elevated myocardial infarction.

Naoki Yoshioka, Kensuke Takagi, Yasuhiro Morita, Ruka Yoshida, Hiroaki Nagai, Yasunori Kanzaki, Koichi Furui, Ryota Yamauchi, Shotaro Komeyama, Hiroki Sugiyama and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frailty as an independent predictor for midterm adverse outcomes in the elderly undergoing primary percutaneous coronary intervention: A longitudinal cohort study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Naoki YoshiokaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Kensuke TakagiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Yasuhiro MoritaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Ruka YoshidaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Hiroaki NagaiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Yasunori KanzakiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Koichi FuruiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Ryota YamauchiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Shotaro KomeyamaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Hiroki SugiyamaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Hideyuki TsuboiDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Itsuro MorishimaDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
Ogaki Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background"Frailty" is associated with poor prognosis in ST-elevated myocardial infarction (STEMI). However, there is little data regarding the impact of the Canadian Study of Health and Aging Clinical Frailty Scale (CFS), a simple and semiquantitative tool for assessing frailty, on mid-term mortality in STEMI patients.

methodsA total of 354 consecutive STEMI patients (mean age 69.8 ± 12.4 years; male 76.6%) who underwent percutaneous intervention between July 2014 and March 2017 were retrospectively reviewed. The study endpoint was mid-term mortality according to the CFS classification. Furthermore, in order to clarify the impact of CFS upon admission on mid-term mortality, the independent predictors of all-cause death were evaluated.

resultsPatients were categorized into three groups (CFS 1-3, n = 281; CFS 4-5, n = 62; and CFS 6-7, n = 11). During the study period (median 474 days), all-cause death was observed in 39 patients. After multivariate Cox regression analysis, higher CFS (adjusted hazard ratio [HR] 2.34, 95% confidence interval [CI] 1.43-3.85, p < 0.001), higher Killip score (adjusted HR 2.46, 95%CI 1.30-5.78, p = 0.002), and lower serum albumin level (adjusted HR 4.29, 95%CI 2.16-8.51, p < 0.001) were significantly associated with an increased risk of all-cause death.

conclusionIn conclusion, severe frailty was associated with mid-term mortality in STEMI patients who underwent PCI.

Indexed as

Coronary heart diseaseFrailPrognosisST-elevated myocardial infarction

Identifiers

PMID30963094
PMCPMC6437299
OpenAlexW2922262962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.